BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) Peer Comparison
$16.83
$0.09
(0.54%)
As on 01-Sep-2026 14:45EDT
Market cap
$1,061 Mln
Revenue (TTM)
$-- Mln
P/E Ratio
6.8
P/B Ratio
1
Div. Yield
0 %
Edit
| BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) | FS KKR Capital (FSK) | Kayne Anderson MLP Investment Closed Fund (KYN) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
1,061 | 3,291 | 2,474 | 2,089 | 1,892 |
Revenue ($ Mln) |
24 | 948 | 185 | 266 | 205 |
Net Profit ($ Mln) |
23.45 | -375.00 | 490.57 | 314.36 | 254.31 |
Net Margin (%) |
-- | -39.56 | 264.61 | -- | -- |
RoE (%) |
3.46 | -6.75 | 19.67 | 20.33 | 13.09 |
Price to Earnings |
6.79 | -- | 5.06 | 6.56 | 7.24 |
Price-To-Book |
1.01 | 0.65 | 0.94 | 1.22 | 0.98 |
Income Statement ($ Mln)
| BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) | FS KKR Capital (FSK) | Kayne Anderson MLP Investment Closed Fund (KYN) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
24.07 | 1,110.00 | 1,210.17 | 274.17 | 321.66 |
|
Cost of Revenue
|
0.00 | 446.00 | 21.41 | 0.00 | 0.00 |
|
Gross Profit
|
24.07 | 664.00 | 1,188.76 | 274.17 | 321.66 |
|
Operating Expenses
|
0.62 | 56.00 | 10.00 | 1.90 | 0.91 |
|
Operating Profit (EBIT)
|
0.93 | 608.00 | 1,178.76 | 272.28 | 320.75 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
23.45 | 608.00 | 1,178.76 | 272.28 | 320.75 |
|
Provision for Tax
|
-- | 23.00 | 249.09 | -- | -- |
|
Profit after Tax (Net Income)
|
23.45 | 585.00 | 929.67 | 272.28 | 320.75 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | 585.00 | -- | -- | -- |
Liabilities ($ Mln)
| BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) | FS KKR Capital (FSK) | Kayne Anderson MLP Investment Closed Fund (KYN) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
768.57 | 6,622.00 | 2,541.49 | 1,374.88 | 1,901.37 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
6.03 | 7,487.00 | 880.75 | 13.42 | 0.56 |
|
Current Liabilities
|
-- | 110.00 | 129.52 | 2.48 | 3.76 |
|
Total Liabilities
|
774.59 | 14,219.00 | 3,551.75 | 1,698.70 | 1,905.68 |
Assets ($ Mln)
| BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) | FS KKR Capital (FSK) | Kayne Anderson MLP Investment Closed Fund (KYN) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
773.33 | 13,550.00 | 3,545.72 | 1,688.79 | 1,894.76 |
|
Current Assets
|
26.56 | 669.00 | 12.68 | 9.91 | 10.92 |
|
Total Assets
|
774.59 | 14,219.00 | 3,551.75 | 1,698.70 | 1,905.68 |
|
Total Debt*
|
0.28 | 7,351.00 | 627.18 | 7.49 | 0.01 |
|
Net Current Assets
|
-- | -- | -- | -- | -- |
Cashflow ($ Mln)
| BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) | FS KKR Capital (FSK) | Kayne Anderson MLP Investment Closed Fund (KYN) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
65.52 | 1,901.00 | 35.40 | 94.11 | -- |
|
Cash Flow from Investing Activities
|
-- | -- | -25.42 | 323.54 | -- |
|
Cash from Financing Activities
|
-65.52 | -1,836.00 | -35.99 | -94.46 | -- |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) | FS KKR Capital (FSK) | Kayne Anderson MLP Investment Closed Fund (KYN) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
3.46 | 4.03 | 35.15 | 21.09 | 17.57 |
|
ROE (%)
|
3.46 | 8.69 | 43.05 | 21.18 | 17.57 |
|
ROA (%)
|
3.42 | 3.94 | 31.10 | 16.22 | 17.53 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
97.44 | 52.70 | 76.82 | 99.31 | 99.72 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) | FS KKR Capital (FSK) | Kayne Anderson MLP Investment Closed Fund (KYN) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
1.94 | -0.10 | 8.83 | 8.99 | 0.27 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
17.17 | -15.95 | 725.74 | -6.16 | 26.74 |
|
EPS Growth (%)
|
0.23 | -0.16 | -- | -0.07 | 0.25 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) | FS KKR Capital (FSK) | Kayne Anderson MLP Investment Closed Fund (KYN) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
8.14 | 10.40 | -- | 2.64 | 5.26 |
|
Price / Book Value
|
0.25 | 0.92 | -- | 0.52 | 0.89 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
177.53 | 21.61 | 0.52 | 2.63 | 5.26 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) | FS KKR Capital (FSK) | Kayne Anderson MLP Investment Closed Fund (KYN) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 1.11 | 0.25 | 0.01 | 0.00 |
|
Short term debt to equity ratio
|
0.00 | 0.00 | 0.04 | 0.01 | 0.00 |
|
Current Ratio
|
-- | 6.08 | 0.10 | 4.00 | 2.91 |
|
Quick Ratio
|
-- | -- | -- | -- | -- |
|
Interest Coverage
|
313,228.00 | 4.28 | 56.96 | -- | -- |
Operating Efficiency Ratios
| BlackRock Health Sciences Trust II of Beneficial Interest (BMEZ) | FS KKR Capital (FSK) | Kayne Anderson MLP Investment Closed Fund (KYN) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
4.97 | 33.60 | 0.45 | 0.06 | 3.34 |
|
Asset Turnover
|
0.04 | 0.07 | 0.40 | 0.16 | 0.18 |
|
Receivable days
|
21.03 | 149.56 | 1.30 | 1.49 | 16.23 |
|
Inventory Days
|
-- | 176.07 | 213.52 | -- | -- |
|
Payable days
|
-- | 165.43 | 85.31 | 162,829.20 | 1,931,335.68 |
|
Cash Conversion Cycle
|
-- | 160.20 | 129.51 | -- | -- |
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
